Recent research demonstrates that the probiotic Limosilactobacillus reuteri colonizing melanoma tissues can release the tryptophan metabolite indole‐3‐acetic acid (I3A), which potently activates CD8+ T cells and significantly enhances the therapeutic efficacy of ICIs [208]. Here, CD8A is linked to melanoma.